LANREOTIDE ACETATE

PeakPeptide

lanreotide acetate

NDASUBCUTANEOUSSOLUTION

Approved

Dec 2021

Lifecycle

Peak

Competitive Pressure

30/100

Mechanism of Action

Lanreotide, the active component of Lanreotide Injection, is an octapeptide analog of natural somatostatin. The mechanism of action of lanreotide is believed to be similar to that of natural somatostatin.

Indications (4)

well moderately differentiated locally advanced metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to improve progression-free survival

External Resources

DailyMed

Full prescribing information

FDA Drugs@FDA

FDA approval history

RxNorm

Drug nomenclature & identifiers